WINDTREE THERAPEUTICS INC /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2016-05-12
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2016-03-31 was 0.00%.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2015-03-31 was 0.00%.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2014-03-31 was 0.00%.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2013-06-30 was 0.00%.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2015 was 0.00%.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2014 was 0.00%.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2013 was 0.00%.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2012 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2016-03-31 | 0.00% 10-Q · filed 2016-05-12 | |||
| 2015-12-31 | 0.00% 10-K · filed 2016-03-29 | |||
| 2015-09-30 | 0.00% 10-Q · filed 2015-11-05 | |||
| 2015-06-30 | 0.00% 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | 0.00% 10-Q · filed 2016-05-12 | |||
| 2014-12-31 | 0.00% 10-K · filed 2016-03-29 | |||
| 2014-09-30 | 0.00% 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | 0.00% 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | 0.00% 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | 0.00% 10-K · filed 2015-03-16 | |||
| 2013-09-30 | 0.00% 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | 0.00% 10-Q · filed 2013-08-08 | 0.00% 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | 0.00% 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | 0.00% 10-K · filed 2015-03-16 | |||
| 2012-09-30 | 0.00% 10-Q · filed 2013-11-12 | |||
| 2012-06-30 | 0.00% 10-Q · filed 2013-08-08 | 0.00% 10-Q · filed 2012-08-14 | ||
| 2012-03-31 | 0.00% 10-Q · filed 2013-05-07 | |||
| 2011-12-31 | 0.00% 10-K · filed 2014-03-17 | |||
| 2011-09-30 | 0.00% 10-Q · filed 2012-11-14 | |||
| 2011-06-30 | 0.00% 10-Q · filed 2012-08-14 | |||
| 2010-12-31 | 0.00% 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |